Dr. Nathan Davis' Publications

1. Davis N, Bargmann W, Lim M-Y, Bose HR, Jr.  Avian Reticuloendotheliosis virus-transformed lymphoid cells contain multiple pp59^v-rel complexes.  J Virol 64:584-591, 1990.

2. Lim M-Y, Davis N, Zhang J, Bose HR, Jr.  The v-rel oncogene product is complexed with cellular proteins including its proto-oncogene product and heat      shock protein 70.  Virology 175:149-160, 1990.

3. Davis JN, Bargmann W, Bose HR, Jr.  Identification of protein complexes containing the c-rel proto-oncogene product in avian hematopoetic cells.  Oncogene 5:1109-1115, 1990.

4. Kerr LD, Inoue J-I, Davis N, Link E, Bauerle PA, Bose HR Jr, Verma I.  The rel-associated pp40 protein prevents DNA binding of REL and NF-kB: Relationship with IkB and regulation by phosphorylation.  Genes Devel 5:1464-1476, 1991.

5. Davis N, Ghosh S, Simmons D, Tempst P, Liou H-C, Baltimore D, Bose HR Jr. Rel-associated pp40: An inhibitor of the rel family of transcription factors. Science 253:1268-1271, 1991.

6. Inoue J-I, Kerr LD, Rashid, Davis N, Bose HR Jr., Verma IM.  Direct association of pp40/IkB with rel/NF-kB proteins: Role of ankyrin repeats in the inhibition of DNA binding activity.  Proc Natl Acad Sci USA 89:4333-4337, 1992.

7.  Roussel MF, Davis JN, Cleveland JL, Ghysdael J, Hiebert SW.  Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F. Oncogene 10: 405-415, 1995.

8. Jeon IS, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, Shapiro DN. A variant Ewing's sarcoma translocation (7; 22) fuses the ews gene to the ets gene etv1. Oncogene:  10: 1229-1234, 1995.

 9. Davis JN and Roussel MF.  Molecular cloning and expression of the cDNA for murine Elf-1.  Gene:  171:265-269, 1996.

10. Ernst P, Hahm K, Trinh L, Davis JN, Roussel MF, Turck CW, Smale ST. A potential role for Elf-1 in terminal transferase gene regulation. Mol Cell Biol 16: 6121-6131, 1996.

11. Hiebert SW, Sun W, Davis JN, Golub T, Shurtleff S, Buijs A, Downing JR, Grosveld G, Roussel MF, Gilliland DG, Lenny N, Meyers S. The t (12; 21) translocation converts AML-1B from an activator to a repressor of transcription. Mol Cell Biol 16: 1349-1355, 1996.

12. Davis JN,  Rock CO, Cheng M, Ashmun RA, Kirk H, Kay R, Roussel MF.  Growth factor receptor-dependent mitogenic signaling mediated by a truncated type  I phosphatidylinositol-4 phosphate 5-kinase.  Mol Cell Biol 17:7398-7406, 1997.

13. Davis JN, Williams BJ, Herron JT, Galiano FJ, Meyers SM.  ETO-2, a new member of the ETO-family of nuclear proteins.  Oncogene, 18, 1375-1383, 1999.

14. Shyng S-L, Barberi A, Gumusboga A, Cukras C, Pike L, Davis JN, Stahl PD, Nichols CG.  Modulation of nucleotide sensitivity of ATP-sensitive potassium channels by phsophatidylinositol-4-phosphate 5-kinase. Proc Natl Acad Sci USA 97:937-941, 2000.

15. Buijs A, van Rompaey L, Molijn AC, Davis JN, Vertegaal AC, Potter MD, Adams C, van Baal S, Zwarthoff EC, Roussel MF, Grosveld GC. The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity. Mol Cell Biol. 20:9281-93, 2000.

16.  Barbieri MA, Heath CM, Peters EM, Wells A, Davis JN, and Stahl PD. Phosphatidylinositol -4-phosphate-5-kinase-1b is essential for EGF-receptor mediated endocytosis. J Biol Chem  276:, 2001.

17.  Galiano FJ, Ulug ET,  and  Davis JN.  Overexpression of murine phosphatidylinositol 4-phosphate 5-kinase disrupts a phosphatidylinositol 4,5 bisphosphate regulated endosomal pathway. J Cell Biochem.  85:131-145, 2002.